Evidence map›Paper›PMID 33036559›Full record

ArticleBMC infectious diseases2020

Assessing the effectiveness of Chagas disease education for healthcare providers in the United States.

Paula Stigler Granados, Gerardo J Pacheco, Evangelina Núñez Patlán, Jose Betancourt, Lawrence Fulton

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Molecular identification ofParasite epidemiology and control · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Chagas disease and perceived quality of life: a cross-sectional study.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Recognition and screening for Chagas disease in the USA.Therapeutic advances in infectious disease
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Paula Stigler GranadosSchool of Health Administration, Texas State University, 601 University Dr, San Marcos, TX, 78666-4606, USA. psgranados@txstate.edu.ORCID http://orcid.org/0000-0002-8993-9879
Gerardo J PachecoSchool of Health Administration, Texas State University, 601 University Dr, San Marcos, TX, 78666-4606, USA.
Evangelina Núñez PatlánSchool of Health Administration, Texas State University, 601 University Dr, San Marcos, TX, 78666-4606, USA.
Jose BetancourtSchool of Health Administration, Texas State University, 601 University Dr, San Marcos, TX, 78666-4606, USA.
Lawrence FultonSchool of Health Administration, Texas State University, 601 University Dr, San Marcos, TX, 78666-4606, USA.
Texas State University · US

Funding

CDC HHS 1U2GGH001640-01CGH CDC HHS U2G GH001640
6 · The paper itself

Abstract

backgroundChagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8-11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20-30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts.

methodsAn online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar's Chi-Square test was used.

resultsThere were statistically significant learning increases in multiple categories including transmission (p = <.001), clinical presentation (p = 0.016), diagnostics (p = <.001), and treatment (p = <.001).

conclusionProviding easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.

Indexed as

Health Knowledge, Attitudes, PracticeTrypanosoma cruziAnimalsChagas DiseaseEducation, VeterinaryEmigrants and ImmigrantsFemaleHealth PersonnelHumansLearningMalePovertyUnited StatesZoonosesChagas diseaseNeglected tropical diseasesOnline medical educationTelehealthTrypanosoma cruzi

Identifiers

PMID33036559
PMCPMC7547496
OpenAlexW3092433286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.